Company Active PRIVATE-LIMITED-GUARANT-NSC

Company profile

Britest Limited

Britest - Home

Homepage for Britest a leading exponent of whole process design for the chemical, pharma and other process manufacturing industries.

CRN
04185316
Founded
2001
Age
25

Overview

Legal name
BRITEST LIMITED
Region
South East England
Registered address
9400 GARSINGTON ROAD
OXFORD BUSINESS PARK
OXFORD
OX4 2HN
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

8 events
31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

09 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

26 Mar
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUxMjc2MTY4MmFkaXF6a2N4

Published 26 Mar 2026 12:16

26 Mar
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUxMjc1OTIyM2FkaXF6a2N4

Published 26 Mar 2026 12:03

23 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

23 Oct
2002

Legacy

Officers

288A | Transaction MTMyMDU2Mzk0YWRpcXprY3g | Paper/PDF filed

Published 31 Oct 2024 07:25

22 Mar
2001

Incorporated

Inception

Company registered at Companies House

Public funding

7 awards
First funded
2013
Funded years
2013, 2014, 2020, 2022, 2024, 2025
Age at first award
12 years

Projects

2025 Feasibility Studies

A sustainable future factory

1 Jan 2025 to 30 Jun 2025

Awarded
£35,726
Total cost £35,726

In response to the growing need for sustainable practices in pharmaceutical manufacturing, our project aims to transform the industry by incorporating cutting-edge technology and data-driven approaches to create eco-friendly factories for the future. Our vision is to revolutionise pharmaceutical manufacturing by integrating robotics and automation, along ...

2024 Centres

RESILIENCE: Medicines Manufacturing Skills Centre of Excellence

1 Apr 2024 to 31 Mar 2026

Awarded
£181,035
Total cost £258,622

The project will establish the RESILIENCE Centre of Excellence for UK Medicines Manufacturing Skills by bringing together the leading regional training providers. There is an urgent need for training and outreach to support the UK life sciences workforce and there is also an opportunity, as a major report states that the sector has the potential to create...

2022 EU-Funded Lead participant

ETERNAL/BRITEST

1 Sep 2022 to 31 Aug 2026

Awarded
£343,262
Total cost £343,262

no public description

2020 Feasibility Studies

LevWave

1 Dec 2020 to 30 Nov 2021

Awarded
£32,601
Total cost £46,573

Driven by a range of sustainability challenges such as climate change, resource depletion and an expanding population, a circular bioeconomy concept is emerging which envisages the use and re-use of sustainable resources to meet pressing societal needs. This will accelerate in the coming decades, with biorefineries and bio-based products as key cornerston...

2014 Collaborative R&D

Digital Design of Drug Products

1 Jun 2014 to 31 May 2016

Awarded
£75,298
Total cost £125,497

This project brings together experts in drug development, product formulation, process design, systems modelling and manufacture to create a completely new approach to the design and manufacture of formulated drug products, which involves the integration of qualitative tools for process understanding with a range of in-silico models which describe and pre...

2013 Feasibility Studies Lead participant

Property Propagation through Process to Product

1 Dec 2013 to 31 Aug 2014

Awarded
£33,747
Total cost £44,996

Britest Ltd is developing a methodology for assessing how the properties of a complex multi-phase formulation propagate through a process into the products on a qualitative/ semi-quantitative basis. The project is a feasibility study to ascertain whether existing tools used by Britest for chemical reaction processes can be modified to gain the required un...

2013 Feasibility Studies Lead participant

Development of biotransformation assessment feasibility methodology

1 Jun 2013 to 30 Nov 2013

Awarded
£20,124
Total cost £26,832

Awaiting Public Project Summary

Product types

Centres Collaborative R&D EU-Funded Feasibility Studies